Air Liquide’s expertise in very low temperatures makes it a natural partner for universities and research centers around the world. The helium-based cryogenic systems it is developing approach absolute zero (-273 °C). They are critical for researchers and especially those working on nuclear fusion as a potential energy source for the future.

 CHEMOXAL

SEPPIC produces biological and speciality products for health and beauty markets (additives, active principles, mainly for skincare, vaccination and pharmaceutical makets)as well as various industrial markets, with an international drive (Asia, Amercias), a stress on “Green products” and significant R&D.

Research lies at the heart of our company. We have brought our Research, Development and Marketing departments together so that our research and development is in touch with market trends.This synergy between research and marketing enables us to develop our skills in our customers' domains.

Air Liquide has been involved in the European space adventure since its beginnings. Several of the Group’s units take an active part in it: in French Guiana, a team is dedicated to the Ariane 5 rocket launch pad; the Cryospace subsidiary builds the hydrogen and oxygen tanks for the rocket’s main stage; the Advanced Technologies Division (DTA) is involved in several aspects of the Ariane program.

In the aeronautics sector, Air Liquide has developed onboard oxygen (OBOGS) and nitrogen (OBIGGS) production systems for planes and helicopters.